ReviewFrontiers in pharmacology2020

Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials.

Xinrong Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.